Pathogenic gut microbe

“Pathogenic gut microbes” is not the name of a single molecule or defined therapeutic target, but rather refers collectively to a broad and diverse group of microorganisms (primarily bacteria, but can also include viruses, fungi, and protozoa) capable of causing disease within the gastrointestinal tract. These microbes can disrupt the balanced symbiotic relationship of the gut microbiota, leading to disorders such as infectious colitis, chronic inflammation (like inflammatory bowel disease), and even promoting colorectal carcinogenesis through mechanisms such as toxin production, mucosal invasion, dysregulation of host immune responses, and metabolic perturbation[1][2][3][4][5][6]. The most clinically important pathogenic bacteria in the gut include species such as Clostridioides difficile, enteropathogenic Escherichia coli, Salmonella, Shigella, Campylobacter, and some Proteobacteria such as pathogenic Enterobacteriaceae[3]. Pathogenicity results from their ability to outcompete commensal flora during dysbiosis, evade host defenses, and produce virulence factors. While interventions such as antibiotics, microbial engineering (e.g., fecal transplant), and targeted probiotics can address gut pathogens, these microbes are a general pathological category rather than a specific molecular or receptor-based drug target[3][6]. Therefore, “pathogenic gut microbes” is not a canonical name for a single receptor or molecule, nor a direct therapeutic target in the sense of druggable proteins; it represents a biological state or collection of entities, and this designation is considered incorrect when referencing specific molecular targets.

Other names

pathogenic gut bacteriaenteric pathogensharmful gut floragut pathogens

competitive inhibition (microbial antagonism with native flora), mucosal invasion, toxin production, immune modulation